DrugPatentWatch Database Preview
Sk Life Company Profile
» See Plans and Pricing
What is the competitive landscape for SK LIFE, and when can generic versions of SK LIFE drugs launch?
SK LIFE has one approved drug.
There is one US patent protecting SK LIFE drugs.
There are nineteen patent family members on SK LIFE drugs in eighteen countries.
Drugs and US Patents for Sk Life
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-002 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | Start Trial | Y | Start Trial | |||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-002 | Mar 10, 2020 | RX | Yes | No | Start Trial | Start Trial | |||||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-001 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | Start Trial | Y | Start Trial | |||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-004 | Mar 10, 2020 | RX | Yes | No | Start Trial | Start Trial | |||||
Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-005 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Sk Life Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 200709994 | Start Trial |
Taiwan | 200722085 | Start Trial |
Taiwan | I398249 | Start Trial |
Spain | 2441765 | Start Trial |
Malaysia | 148589 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.